Atlas Trials

Study of Vidaza (Azacitidine) Versus Support Treatment in Patients With Low Risk Myelodysplastic Syndrome (Low and Intermediate-1 IPSS) Without the 5q Deletion and Transfusion Dependent Anaemia

Clinical trial NCT01338337 · COMPLETED

Trial details

NCT number
NCT01338337
Sponsor
Asociación Andaluza de Hematología y Hemoterapia
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Myelodysplastic Syndrome (MDS)
Start date
2010-11-01
Primary completion
2015-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.